Published in Mol Pharm on June 03, 2009
AVPpred: collection and prediction of highly effective antiviral peptides. Nucleic Acids Res (2012) 0.98
Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin. BMC Struct Biol (2014) 0.85
Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides. FEBS Lett (2015) 0.81
Investigating the nucleic acid interactions of histone-derived antimicrobial peptides. FEBS Lett (2017) 0.75
Identification of bitterness-masking compounds from cheese. J Agric Food Chem (2012) 0.75
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm (2012) 1.51
The pharmacophore of short cationic antibacterial peptides. J Med Chem (2003) 1.35
Synthetic antimicrobial peptidomimetics with therapeutic potential. J Med Chem (2008) 1.14
Protein O-mannosylation is crucial for cell wall integrity, septation and viability in fission yeast. Mol Microbiol (2005) 1.13
Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res (2003) 1.12
Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochem Cell Biol (2002) 1.07
Antimicrobial activity of short arginine- and tryptophan-rich peptides. J Pept Sci (2002) 1.05
Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect. J Med Chem (2007) 0.98
The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. J Pept Sci (2004) 0.94
Antimicrobial peptides with stability toward tryptic degradation. Biochemistry (2008) 0.93
Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation. Appl Environ Microbiol (2014) 0.91
Synthesis of cationic antimicrobial β(2,2)-amino acid derivatives with potential for oral administration. J Med Chem (2011) 0.90
Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J Med Chem (2004) 0.88
In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives. Eur J Pharm Sci (2011) 0.87
Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity. J Biol Chem (2011) 0.87
Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid. Chem Phys Lipids (2009) 0.86
Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound. Int J Pharm (2010) 0.85
Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability. J Pharmacol Exp Ther (2009) 0.85
Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface. Eur J Pharm Sci (2004) 0.85
Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement. Int J Pharm (2012) 0.85
A method to determine the incorporation capacity of camptothecin in liposomes. AAPS PharmSciTech (2004) 0.85
Asymmetric flow field-flow fractionation of liposomes: optimization of fractionation variables. J Sep Sci (2009) 0.84
Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. Eur J Pharm Sci (2005) 0.84
Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins. J Pept Sci (2004) 0.83
Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery. Eur J Pharm Biopharm (2010) 0.83
In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides. J Med Chem (2011) 0.83
Liposome size analysis by dynamic/static light scattering upon size exclusion-/field flow-fractionation. J Nanosci Nanotechnol (2006) 0.82
Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides. J Pept Sci (2002) 0.82
Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations". Eur J Pharm Sci (2013) 0.82
Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound. Eur J Pharm Sci (2012) 0.82
Assessing the accuracy of routine photon correlation spectroscopy analysis of heterogeneous size distributions. AAPS PharmSciTech (2003) 0.81
Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers. Eur J Pharm Biopharm (2011) 0.81
Liposomal solubilization of new 3-hydroxy-quinolinone derivatives with promising anticancer activity: a screening method to identify maximum incorporation capacity. J Liposome Res (2011) 0.81
Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix. Eur J Pharm Biopharm (2005) 0.81
The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility. Int J Nanomedicine (2012) 0.81
Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci (2010) 0.81
Thermodynamics and structure of a salmon cold active goose-type lysozyme. Comp Biochem Physiol B Biochem Mol Biol (2010) 0.81
Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride. J Liposome Res (2014) 0.80
Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. Eur J Pharm Sci (2006) 0.80
Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies. J Pharm Biomed Anal (2011) 0.80
Magnetic fluorescent microparticles as markers for particle transfer in extracorporeal blood purification. Biomacromolecules (2007) 0.79
Comparison of NMR structures and model-membrane interactions of 15-residue antimicrobial peptides derived from bovine lactoferricin. Biochem Cell Biol (2006) 0.79
Unnatural amino acid side chains as S1, S1', and S2' probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation. J Med Chem (2010) 0.79
Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin. Int J Pharm (2004) 0.79
Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine. Eur J Pharm Sci (2011) 0.79
What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? J Pharm Sci (2014) 0.79
The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin. J Pept Sci (2002) 0.79
Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions. J Pharm Biomed Anal (2004) 0.79
Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability. Eur J Pharm Sci (2008) 0.79
A target-oriented algorithm for citrate-calcium anticoagulation in clinical practice. Blood Purif (2013) 0.78
Synthesis of anticancer heptapeptides containing a unique lipophilic β(2,2) -amino acid building block. J Pept Sci (2012) 0.78
In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation. J Pharm Biomed Anal (2010) 0.78
Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration. J Med Chem (2012) 0.78
Camptothecin-catalyzed phospholipid hydrolysis in liposomes. Int J Pharm (2004) 0.78
Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid. J Pept Sci (2012) 0.78
Structural characterization of ether lipids from the archaeon Sulfolobus islandicus by high-resolution shotgun lipidomics. J Mass Spectrom (2015) 0.78
Fluidized bed adsorbent systems for extracorporeal liver support. Ther Apher Dial (2006) 0.78
Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability. Eur J Pharm Sci (2006) 0.78
Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs (2007) 0.78
In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants. J Pharm Pharmacol (2011) 0.78
Determination of the size distribution of liposomes by SEC fractionation, and PCS analysis and enzymatic assay of lipid content. AAPS PharmSciTech (2002) 0.77
Quantification of various phosphatidylcholines in liposomes by enzymatic assay. AAPS PharmSciTech (2003) 0.77
Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. Eur J Pharm Sci (2012) 0.77
Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc). J Pept Sci (2002) 0.76
Physicochemical characterization of liposomes after ultrasound exposure - mechanisms of drug release. J Pharm Biomed Anal (2013) 0.76
Asymmetric flow field-flow fractionation of liposomes: 2. Concentration detection and adsorptive loss phenomena. J Sep Sci (2009) 0.76
Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials. Bioorg Med Chem Lett (2006) 0.76
Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin. Eur J Pharm Sci (2011) 0.76
Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin. J Liposome Res (2013) 0.75
In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. J Pharm Pharmacol (2010) 0.75
Compressibility study of quaternary phospholipid blend monolayers. Colloids Surf B Biointerfaces (2011) 0.75
Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188. J Pharm Pharmacol (2012) 0.75
Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution. J Liposome Res (2012) 0.75
Asymmetrical flow field-flow fractionation with on-line detection for drug transfer studies: a feasibility study. Anal Bioanal Chem (2014) 0.75
Boron-containing peptidomimetics--a novel class of selective anti-tubercular drugs. Chem Biol Drug Des (2012) 0.75
Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels. Anticancer Drugs (2002) 0.75
Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay. Int J Pharm (2011) 0.75
Evaluation of a simple method for visual detection of microprecipitates in blends of parenteral drug solutions using a focused (tyndall) light beam. Int J Pharm Compd (2013) 0.75
Cytotoxic effect of different camptothecin formulations on human colon carcinoma in vitro. Anticancer Drugs (2004) 0.75
Particle leakage in extracorporeal blood purification systems based on microparticle suspensions. Blood Purif (2005) 0.75
Anticancer potency of small linear and cyclic tetrapeptides and pharmacokinetic investigations of peptide binding to human serum albumin. J Pept Sci (2014) 0.75
Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules. J Med Chem (2016) 0.75